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Abstract
Epistasis (gene-gene interaction) is a ubiquitous component of the genetic architecture of complex traits such as
susceptibility to common human diseases. Given the strong negative correlation between circulating adiponectin
and resistin levels, the potential intermolecular epistatic interactions between ADIPOQ (SNP+45T > G, SNP+276G >
T, SNP+639T > C and SNP+1212A > G) and RETN (SNP-420C > G and SNP+299G > A) gene polymorphisms in the
genetic risk underlying type 2 diabetes (T2DM) and metabolic syndrome (MS) were assessed. The potential mutual
influence of the ADIPOQ and RETN genes on their adipokine levels was also examined. The rare homozygous geno-
type (risk alleles) of SNP-420C > G at the RETN locus tended to be co-inherited together with the common homozy-
gous genotypes (protective alleles) of SNP+639T > C and SNP+1212A > G at the ADIPOQ locus. Despite the close
structural relationship between the ADIPOQ and RETN genes, there was no evidence of an intermolecular epistatic
interaction between these genes. There was also no reciprocal effect of the ADIPOQ and RETN genes on their
adipokine levels, i.e., ADIPOQ did not affect resistin levels nor did RETN affect adiponectin levels. The possible influ-
ence of the ADIPOQ gene on RETN expression warrants further investigation.
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Adiponectin and resistin are important hormones in
the regulation of insulin sensitivity (insulin secretion and
signaling pathway), energy homeostasis (glycogen synthe-
sis and glycogenolysis), glucose metabolism (gluconeo-
genesis, glucose uptake and use) and lipid metabolism
(fatty acid synthesis and oxidation) (Lau and Muniandy,
2011a). We have recently shown that the mutual regulation
of adiponectin and resistin is an important determinant of
metabolic disturbances, cardiometabolic function and
global metabolic status (Lau and Muniandy, 2011a). More-
over, the relative proportion of adiponectin-to-resistin lev-
els reflect metabolic homeostasis and metabolic disorders
much better than adiponectin and resistin levels alone, with
a significant inverse correlation between the levels of these
two hormones (Lau and Muniandy, 2011a). The similar do-
main architecture of these adipokines, despite their diamet-
rically opposed physiological effects, suggests a common
regulatory mechanism in metabolic homeostasis (Patel et
al., 2004). Single nucleotide polymorphisms (SNPs) have
been identified in the ADIPOQ (SNP+45T > G, SNP+276G
> T, SNP+639T > C and SNP+1212A > G) and RETN
(SNP-420C > G and SNP+299G > A) genes. These SNPs of
the ADIPOQ (Zhao and Zhao, 2011) and RETN (Wen et al.,
2010) genes are the most widely studied for their etiologi-
cal links to the risk of type 2 diabetes mellitus (T2DM) and
metabolic syndrome (MS). In general, T2DM and MS do
not follow a Mendelian pattern of inheritance.
There is increasing evidence that gene-gene interac-
tions (epistasis) play a far more important role in an indi-
vidual’s susceptibility to these complex diseases than sin-
gle polymorphisms on their own since one gene can
enhance or hinder the expression of another gene (Moore,
2003). Moreover, there is a growing awareness that the fail-
ure to replicate single-locus association studies for com-
mon diseases may reflect an underlying genetic architec-
ture in which interactions between genes are the norm
rather than the exception (Lehner, 2011). Epistasis occurs
when the developmental or physiological effects of a ge-
netic difference at one locus depend on the genotype at an-
other locus, perhaps on a different chromosome (Desai et
al., 2007). This dependence is often a consequence of an
underlying functional relationship between the two genes
(Lehner, 2011). Since epistasis is a ubiquitous component
of the genetic architecture of complex diseases, analysis of
the combined effects of the ADIPOQ and RETN genes may
provide more information about the risk of T2DM and MS
than the analysis of a single gene.
Given the strong negative correlation between circu-
lating adiponectin and resistin levels, in this work we exam-
ined the potential intermolecular epistatic interactions
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between ADIPOQ and RETN gene polymorphisms in the
genetic risk underlying T2DM and MS. The potential mu-
tual influence of the ADIPOQ and RETN genes on their
adipokine levels was also examined. The results of this
study provide a better understanding of the intermolecular
interactions between ADIPOQ and RETN gene polymor-
phisms that underlie the pathogenesis of T2DM and MS.
Such an analysis of genetic interactions can reveal implicit
structural and functional relationships between the
ADIPOQ and RETN genes and may provide useful insights
for developing therapeutic approaches to treat T2DM and
MS.
All subjects were native Malaysian males 40-70 years
old from three major ethnic groups (Malay, Chinese and In-
dian). This study was approved by the University of Malaya
Medical Centre (UMMC) Ethics Committee (Ethical Ap-
proval Letter no. 612.17). Informed consent was obtained
from each participant after thorough explanation of the
study. Each subject received a detailed questionnaire about
his personal and family history of disease and demographic
data. Eight hundred and nine subjects were enrolled in a
case-control study in which there were 208 controls, 174 in-
dividuals with MS but no T2DM, 171 individuals with
T2DM but no MS and 256 individuals with T2DM and MS.
MS was defined according to the International Diabetes
Federation 2005 diagnostic criteria (Alberti et al., 2005).
The sampling method used and the characteristics of this
study have been described elsewhere (Lau and Muniandy,
2011a,b).
The subjects were screened for metabolic parameters
that included serum fasting levels of adiponectin, resistin,
insulin, total cholesterol, LDL cholesterol, HDL choles-
terol, triglycerides, plasma glucose and whole blood
HbA1C. The anthropometric parameters that were mea-
sured or calculated included blood pressure, body mass in-
dex (BMI), waist circumference and waist-to-hip ratio
(WHR). -Cell function (HOMA% index), insulin sensi-
tivity (HOMA%S index) and insulin resistance (HOMA-IR
index) were calculated with HOMA calculator software
version 2.2.2 (Diabetes Trials Unit, Oxford University).
The clinical characteristics and demographic parameters of
the subjects have been reported elsewhere (Lau and Mu-
niandy, 2011a).
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Figure 1 - Dimension reduction correspondence analysis of SNP-420C > G showing biplot results for (A) SNP-420C > G and SNP+45T > G, (B)
SNP-420C > G and SNP+276G > T, (C) SNP-420C > G and SNP+639T > C and (D) SNP-420C > G and SNP+1212A > G. The total sample size was 809.
The model settings included two dimensions in solution, Euclidean distance measurements, default standardization and symmetrical normalization meth-
ods. A biplot illustrates the underlying structural relationships between two SNPs. Projecting the genotypes for one SNP on the vector from the origin to a
genotype for the other SNP describes the structural relationship between the SNPs. The distance between genotypes in a plot reflects the strength of the re-
lationship between the genotypes, with associated genotypes being plotted close to each other. Genotypes that are closer to each other are more alike
(co-inherited) than those that are farther apart. Note: RETN (SNP-420C > G); ADIPOQ (SNP+45T > G, SNP+276G > T, SNP+639T > C,
SNP+1212A > G).
Genomic DNA was extracted from whole blood using
a Wizard Genomic DNA purification kit (Promega Corpo-
ration, Madison, WI, USA). SNPs were genotyped using
Custom TaqMan® SNP Genotyping assay kits (Applied
Biosystems, Foster City, CA, USA) according to the manu-
facturer’s standard protocol. Allelic discrimination analy-
sis was done with a StepOnePlus real-time PCR system
version 2.0 (Applied Biosystems). All of the SNPs passed
the pre-defined threshold for genotyping call rate. Only
subjects with a high genotyping call rate (quality value 
98%) were included in the study. Primers and PCR condi-
tions were designed to amplify the DNA region of each
SNP marker. Thirty samples were randomly selected for
forward and reverse DNA sequencing (AITBiotech Pte
Ltd., Singapore) to verify the genotyping results for each
SNP marker. Details of the genotyping and DNA sequenc-
ing procedures are described elsewhere (Lau and Munian-
dy, 2011b).
Dimension reduction correspondence analysis to ex-
amine the structural relationships between two SNPs in
low-dimensional space was done using the PASW Statis-
tics 18 Program (SPSS Inc, Chicago, IL, USA). Quantita-
tive traits analysis for alleles was done using the
HAPSTAT program, version 3.0 (Chapel Hill, NC, USA).
In the additive model, an empirical p value was generated
after Bonferroni correction with adjusted known confound-
ing factors. The potential nonlinear interactions between
ADIPOQ and RETN gene polymorphisms were analyzed
with the Generalized Multifactor Dimensionality Reduc-
tion (GMDR) Beta program, version 0.7 (University of Vir-
ginia, Charlottesville, VA, USA). GMDR analysis included
a combined cross-validation/permutation testing procedure
that prevented model over-fitting and minimized false-
positive results generated by multiple comparisons. Ethnic-
ity was stratified before analysis. All p values were two-
tailed, and p values < 0.05 were considered statistically sig-
nificant.
SNP-420C > G of the RETN gene showed a strong
structural relationship with SNP+639T > C and
SNP+1212A > G of the ADIPOQ gene (Figure 1). The het-
erozygous genotype of SNP-420C > G tended to be co-
inherited together with the heterozygous genotypes of
SNP+639T > C (Figure 1C) and SNP+1212A > G (Fig-
ure 1D). SNP+299G > A of the RETN gene shared a strong
structural relationship with SNP+639T > C of the ADIPOQ
gene (Figure 2). The common homozygous genotypes of
SNP+299G > A and SNP+639T > C tended to be co-
inherited (Figure 2C). Interestingly, the rare homozygous
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Figure 2 - Dimension reduction correspondence analysis of SNP+299G > A showing biplot results for (A) SNP+299G > A and SNP+45T > G, (B)
SNP+299G > A and SNP+276G > T, (C) SNP+299G < A and SNP+639T > C and (D) SNP+299G > A and SNP+1212A > G. The total sample size was
809. See the legend for Figure 1 for details of the model settings and the interpretation of biplots. Note: RETN (SNP+299G > A); ADIPOQ (SNP+45T >
G, SNP+276G > T, SNP+639T > C, SNP+1212A > G).
genotype of SNP-420C > G was generally co-inherited
with the common homozygous genotypes of SNP+639T <
C (Figure 1C) and SNP+1212A < G (Figure 1D). Further-
more, the rare homozygous genotypes of these SNPs at the
ADIPOQ and RETN loci were unlikely to be co-inherited
(Figures 1 and 2), which suggested a possible antagonistic
relationship between the ADIPOQ and RETN genes.
Despite the above relationships, there were no inter-
actions between ADIPOQ (SNP+45T > G, SNP+276G > T,
SNP+639T > C and SNP+1212A > G) and RETN (SNP-
420C > G and SNP+299G > A) gene polymorphisms and
their adipokine levels (Table 1). GMDR analysis showed
that none of these SNP combinations was associated with
the risk of T2DM and MS among Malaysian Malay, Chi-
nese and Indian men (Table 2). Despite the close structural
relationship between the ADIPOQ and RETN genes (Fig-
ures 1 and 2), the functional relationship between these
genes was unclear (Tables 1 and 2). The extent to which the
structural relationship observed here was related to gene
transcriptional activity (adipokine levels) and/or metabolic
disturbances (risk of T2DM and MS) remains to be deter-
mined.
Genome-based linkage and association studies have
shown marked variations in the circulating levels of adipo-
nectin (Henneman et al., 2010) and resistin (Menzaghi et
al., 2006). We have previously reported a strong associa-
tion between RETN gene polymorphisms and resistin lev-
els, but only a marginal association between ADIPOQ gene
polymorphisms and adiponectin levels (Lau and Munian-
dy, 2011b). Recent comprehensive linkage disequilibrium
mapping studies have shown that ADIPOQ (Heid et al.,
2010) and RETN (Asano et al., 2010) gene polymorphisms,
including the SNPs examined here, account for the high
variablity in the levels of their respective adipokines. Nev-
ertheless, the genetic epistasis of adiponectin and resistin
remain largely unexplored.
The results described here show that the ADIPOQ and
RETN genes did not have a reciprocal effect on their
adipokine levels, i.e., ADIPOQ did not affect resistin levels
nor did RETN affect adiponectin levels (Table 1). To our
knowledge, an association between RETN gene poly-
morphisms and adiponectin levels has been reported in
only one study in which the G-allele of SNP-420C > G at
the RETN locus was associated with lower circulating adi-
ponectin levels in Japanese patients (Miyamoto et al.,
2009). The present study is the first to examine the associa-
tion between ADIPOQ gene polymorphisms and resistin
levels. Although not statistically significant, the C-allele of
Lau and Muniandy 41
Table 1 - Estimative effect of alleles on adipokine levels.
ADIPOQ gene polymorphisms Resistin (ng/mL) (n = 809) Nominal p value Empirical p value
SNP+45T > G (rs2241766)
T-allele (78.18%) +0.3415 (0.7756) 0.6597 1.0000
G-allele (21.82%) -0.3415 (0.7756)
SNP+276G > T (rs1501299)
G-allele (70.52%) +1.0562 (0.7161) 0.1402 0.4157
T-allele (29.48%) -1.0562 (0.7161)
SNP+639T > C (rs3821799)
T-allele (56.37%) -1.0448 (0.6485) 0.1072 0.3078
C-allele (43.63%) +1.0448 (0.6485)
SNP+1212A > G (rs6773957)
A-allele (51.17%) -1.1663 (0.6435) 0.0699 0.1910
G-allele (48.83%) +1.1663 (0.6435)
RETN gene polymorphisms Adiponectin (g/mL) (n = 809) Nominal p value Empirical p value
SNP-420C > G (rs1862513)
C-allele (58.65%) +0.0654 (0.2270) 0.7733 1.0000
G-allele (41.35%) -0.0654 (0.2270)
SNP+299G > A (rs3745367)
G-allele (63.84%) +0.2470 (0.2256) 0.2735 0.7912
A-allele (36.16%) -0.2470 (0.2256)
The results are expressed as the estimative effect (standard error in parentheses). The nominal p value was generated after adjusting for covariate age, eth-
nicity, body mass index (BMI), type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS). The empirical p value was generated after performing the
Bonferroni correction and adjusting for covariate age, ethnicity, BMI, T2DM and MS. The Bonferroni correction was used to counteract the problem of
multiple comparisons by controlling for false positive results (type I errors). The estimative effect reflects the change in the mean serum resistin or
adiponectin levels associated with a single allele.
SNP+639T > C and the G-allele of SNP+1212A > G at the
ADIPOQ locus possibly provided a small contribution to
the elevated serum resistin levels in individuals with these
polymorphisms (Table 1). Recent large scale genome-wide
association studies have suggested that these rare alleles are
also associated with an increased risk of hypoadiponec-
tinemia (Ling et al., 2009; Heid et al., 2010). Since the
ADIPOQ and RETN genes encode functionally-related pro-
teins, a deleterious mutation in the ADIPOQ gene could in-
directly interfere with RETN expression (probably through
adipokine interaction or metabolic pathway rather than via
genetic regulation). In agreement with this conclusion,
genes with similar molecular functions normally have simi-
lar epistatic interactions. Thus, if in a particular condition
two metabolic pathways can produce the same metabolite,
then inactivation of either pathway alone will have little ef-
fect on fitness (Lehner, 2011).
Paradoxically, the rare homozygous genotype (risk
alleles) of SNP-420C > G at the RETN locus tended to be
co-inherited with the common homozygous genotypes
(protective alleles) of SNP+639T > C (Figure 1C) and
SNP+1212A > G (Figure 1D) at the ADIPOQ locus. The
T-allele of SNP+639T > C and the A-allele of SNP+1212A
> G have a protective effect against T2DM and MS (Heid et
al., 2010; Siitonen et al., 2011), whereas the G-allele of
SNP-420C > G triggers these conditions (Ochi et al., 2007;
Miyamoto et al., 2009). Recombination between SNPs in
these genes may prevent disease-causing alleles of these
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Table 2 - Generalized multifactor dimensionality reduction analysis.
Group
comparisons










Malay men (n = 281)
Control (n = 75)
vs.
MS without T2DM (n = 62)
SNP+299G > A, SNP+45T > G,
SNP+639T > C
68.85% 62.02% 7 (0.1719) 10/10
Control (n = 75)
vs.
T2DM without MS (n = 43)
SNP+299G > A, SNP+45T > G,
SNP+276G > T
69.26% 53.82% 6 (0.3770) 9/10
Control (n = 75)
vs.
T2DM with MS (n = 101)
SNP+45T > G, SNP+639T > C 63.37% 59.27% 7 (0.1719) 7/10
Chinese men (n = 264)
Control (n = 73)
vs.
MS without T2DM (n = 54)
SNP-420C > G, SNP+299G > A,
SNP+45T > G SNP+639T > C
72.61% 48.62% 4 (0.8281) 6/10
Control (n = 73)
vs.
T2DM without MS (n = 62)
SNP-420C > G, SNP+299G > A,
SNP+639T > C
72.66% 63.76% 8 (0.0547) 10/10
Control (n = 73)
vs.
T2DM with MS (n = 75)
SNP-420C > G, SNP+299G > A,
SNP+276G > T
68.70% 51.70% 5 (0.6230) 8/10
Indian men (n = 264)
Control (n = 60)
vs.
MS without T2DM (n = 58)
SNP+299G > A, SNP+276G > T 66.23% 55.33% 6 (0.3770) 10/10
Control (n = 60)
vs.
T2DM without MS (n = 66)
SNP-420C > G, SNP+299G > A,
SNP+1212A > G
66.89% 59.60% 7 (0.1719) 9/10
Control (n = 60)
vs.
T2DM with MS (n = 80)
SNP-420C > G, SNP+299G > A,
SNP+276G > T, SNP+639T > C
68.08% 51.02% 5 (0.6230) 10/10
Significance test: n indicates the number of tests with accuracies greater than 50% and, in parentheses (pE), the empirical p value (after correction for mul-
tiple comparisons) computed from 1,000,000 permutations. The exhaustive search method configuration was used. With a 10-fold cross-validation, the
data are divided into 10 equal parts and the model is developed on 9/10 of the data (training set) and then tested on 1/10 of the remaining data (testing set).
This is repeated for each possible combination of 9/10 (training balance accuracy) and 1/10 (testing balance accuracy) of the data, with the resulting 10
testing accuracies then being averaged. The cross-validation consistency is a measure of how many times out of 10 divisions of the data that GMDR found
the same best model. The model with the combination of SNPs that maximized the average cross-validation consistency and minimized the average pre-
diction error was selected. Note: RETN (SNP-420C > G and SNP+299G > A); ADIPOQ (SNP+45T > G, SNP+276G > T, SNP+639T > C and
SNP+1212A > G); T2DM = type 2 diabetes mellitus; MS = metabolic syndrome.
SNPs from being co-inherited. Indeed, some studies have
reported a prevalence of antagonistic epistasis, i.e., the ten-
dency of multiple mutations to have a mitigating/alleviat-
ing effect rather than a reinforcing/aggravating effect
(Desai et al., 2007). Recombination and mutations provide
the basis for less synergistic or more antagonistic epistasis
(Desai et al., 2007). The results described here provide no
conclusive evidence for a link between the structural simi-
larity and/or functional similarity (synergistic or antagonis-
tic epistasis) between these two genes. Indeed, the extent to
which the ADIPOQ gene interferes with RETN expression
remains to be determined.
Although ADIPOQ and RETN are located on differ-
ent chromosomes, the intermolecular epistatic interaction
between these genes is possible (Charalampos and Richard,
2006). Epistatic interactions between mutations in different
genes may be caused by different underlying molecular
mechanisms (Lehner, 2011). If two genes share a common
function, then the loss of one gene could be compensated
for by continued activity of the second gene (Lehner,
2011). Since adiponectin and resistin have opposite physio-
logical effects (Lau and Muniandy, 2011a), polymorphisms
in ADIPOQ and RETN are likely to affect disease outcome
by acting antagonistically during natural selection. Despite
the structural similarity between ADIPOQ and RETN (Fig-
ures 1 and 2), there was no evidence of an intermolecular
epistatic interaction between these genes (Table 2). The
ADIPOQ and RETN genes may not, by themselves, exhibit
a significant association with the risk of T2DM and MS be-
cause their combined effect may be relatively small and de-
pendent on genotypes at other loci; the latter may compen-
sate for variation in the loci under study and may differ
across populations. Indeed, recent large-scale systematic
reviews and meta-analyses have shown marked heteroge-
neity among SNPs associated with the ADIPOQ (Zhao and
Zhao, 2011) and RETN (Wen et al., 2010) loci.
The findings of this study relate to Malaysian men
and may not be applicable to other groups because of ge-
netic differences. Fine-mapping studies are needed since
our investigation did not cover upstream and downstream
variations in the ADIPOQ and RETN genes. Comprehen-
sive linkage disequilibrium mapping and haplotype-based
data mining would allow a detailed analysis of haploty-
pe-haplotype interactions and more insight into the genetic
risk factors associated with T2DM and MS. In addition to
the ADIPOQ and RETN genes, other genes involved in the
susceptibility to T2DM and MS should be included when
modelling high-order gene-gene interactions. The avail-
ability of more powerful computer-based approaches will
allow large scale genome-proteome interaction-based anal-
yses to map epistatic interactions on a wider scale. In this
context, understanding the role of “gene-environment” in-
teractions is crucial for the characterization of low-
penetrance genes. Further studies with larger sample sizes
than that used here are required in order to reach more reli-
able conclusions.
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